These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 287029

  • 1. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
    Fibach E, Gambari R, Shaw PA, Maniatis G, Reuben RC, Sassa S, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1906-10. PubMed ID: 287029
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.
    Yamasaki H, Drevon C, Martel N.
    Carcinog Compr Surv; 1982 Apr; 7():359-77. PubMed ID: 7039831
    [No Abstract] [Full Text] [Related]

  • 7. Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.
    Rovera G, O'Brien TG, Diamond L.
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2894-8. PubMed ID: 268640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.
    Fibach E, Yamasaki H, Weinstein IB, Marks PA, Rifkind RA.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3685-8. PubMed ID: 279396
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycle.
    Gambari R, Fibach E, Rifkind RA, Marks PA.
    Biochem Biophys Res Commun; 1980 Jun 16; 94(3):867-74. PubMed ID: 7396937
    [No Abstract] [Full Text] [Related]

  • 11. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells.
    Mitsuse S, Oishi M.
    Cancer Res; 1985 Aug 16; 45(8):3836-42. PubMed ID: 3860288
    [Abstract] [Full Text] [Related]

  • 12. Desferrioxamine-mediated inhibition of heme and hemoglobin synthesis in murine erythroleukemia cells: expression of globin genes and commitment to erythroid differentiation.
    Gambari R.
    Cell Biol Int Rep; 1983 Oct 16; 7(10):785-95. PubMed ID: 6580089
    [Abstract] [Full Text] [Related]

  • 13. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells.
    Pilz RB.
    J Biol Chem; 1993 Sep 25; 268(27):20252-8. PubMed ID: 8376386
    [Abstract] [Full Text] [Related]

  • 14. Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects.
    Giroldi L, Hollstein M, Yamasaki H.
    Carcinogenesis; 1988 May 25; 9(5):817-21. PubMed ID: 3163274
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.
    Mallia CM, Aguirre V, McGary E, Tang Y, Scandurro AB, Liu C, Noguchi CT, Beckman BS.
    Exp Cell Res; 1999 Feb 01; 246(2):348-54. PubMed ID: 9925750
    [Abstract] [Full Text] [Related]

  • 16. Tumor promoter-mediated effects on Friend leukemia cells induced by actinomycin D: flow microfluorometry analysis and erythroid differentiation.
    Gambari R.
    Basic Appl Histochem; 1982 Feb 01; 26(3):163-72. PubMed ID: 7138458
    [Abstract] [Full Text] [Related]

  • 17. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
    Watanabe T, Shafman T, Kufe DW.
    J Cell Physiol; 1985 Mar 01; 122(3):435-40. PubMed ID: 3918047
    [Abstract] [Full Text] [Related]

  • 18. Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants.
    Weich N, Marks PA, Rifkind RA.
    Blood; 1990 Jul 15; 76(2):302-6. PubMed ID: 2369636
    [Abstract] [Full Text] [Related]

  • 19. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ.
    Exp Hematol; 1993 Jan 15; 21(1):169-76. PubMed ID: 8417953
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythroleukemia cells.
    Tsiftsoglou AS, Gusella JF, Volloch V, Housman DE.
    Cancer Res; 1979 Oct 15; 39(10):3849-55. PubMed ID: 289436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.